| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activity and Safety of Oxaliplatin with Weekly 5-Fluorouracil Bolus and Low-Dose Leucovorin as First-Line Treatment for Advanced Colorectal Cancer
|
Cassinello, Javier
|
|
2003
|
3 |
2 |
p. 108-112
5 p.
|
article
|
| 2 |
Adding a Humanized Antibody to Vascular Endothelial Growth Factor (Bevacizumab, Avastin™) to Chemotherapy Improves Survival in Metastatic Colorectal Cancer
|
D'Orazio, Amy
|
|
2003
|
3 |
2 |
p. 85-88
4 p.
|
article
|
| 3 |
Adenomatous Polyposis Coli/β-Catenin Interaction and Downstream Targets: Altered Gene Expression in Gastrointestinal Tumors
|
Clements, Wilson M.
|
|
2003
|
3 |
2 |
p. 113-120
8 p.
|
article
|
| 4 |
Capecitabine in Combination with Irinotecan or Oxaliplatin in Advanced Colorectal Cancer
|
D'Orazio, Amy
|
|
2003
|
3 |
2 |
p. 89-91
3 p.
|
article
|
| 5 |
Capecitabine-Related Neurotoxicity Presenting as Trismus
|
Couch, Linda S.B.
|
|
2003
|
3 |
2 |
p. 121-123
3 p.
|
article
|
| 6 |
Highlights From: 39th Annual Meeting of the American Society of Clinical Oncology; Chicago, Illinois May 31 to June 3, 2003
|
DeGrendele, Heather C.
|
|
2003
|
3 |
2 |
p. 78-84
7 p.
|
article
|
| 7 |
Impact of 5-Fluorouracil Rechallenge on Subsequent Response and Survival in Advanced Colorectal Cancer: Pooled Analysis from Three Consecutive Randomized Controlled Trials
|
Yeoh, Cheng
|
|
2003
|
3 |
2 |
p. 102-107
6 p.
|
article
|
| 8 |
Lynch Syndrome: Implications for the Surgeon
|
Scaife, Cournety L.
|
|
2003
|
3 |
2 |
p. 92-98
7 p.
|
article
|
| 9 |
Role of Prophylactic Colectomy in Lynch Syndrome
|
Lynch, Henry T.
|
|
2003
|
3 |
2 |
p. 99-101
3 p.
|
article
|
| 10 |
Validation of the Role of Angiogenesis as a Chemotherapeutic Target
|
Chu, Edward
|
|
2003
|
3 |
2 |
p. 74-75
2 p.
|
article
|
Journal description